Hemoglobin A1C (HbA1C) Testing

Hemoglobin A1C (HbA1C) Testing

Global Hemoglobin A1C (HbA1C) Testing Market to Reach $2.3 Billion by 2030
The global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.4 Billion in the year 2022, is expected to reach US$2.3 Billion by 2030, growing at a CAGR of 6.9% over the period 2022-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC) Technology segment is expected to record 7.6% CAGR and reach US$915.7 Million by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 8.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $397.5 Million, While China is Forecast to Grow at 9.5% CAGR
The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$397.5 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$274.2 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 110 Featured) -
  • Abbott Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • A. Menarini Diagnostics Srl
  • Apex Biotechnology Corporation
  • Axis-Shield Diagnostics Ltd.
  • Agappe Diagnostics Ltd.
  • Biorex Diagnostics
  • Boditech Med, Inc.
  • Biosurfit SA
  • Accruex Biomedical Pvt., Ltd.
  • Ailex Technology Group Co., Ltd.
  • American Screening Corporation, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Competition
Hemoglobin A1C (HbA1C) Testing - Global Key Competitors Percentage Market Share in 2022 (E)
Hemoglobin A1C (HbA1C) Testing Competitor Market Share Scenario Worldwide (in %): 2022E
HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
Role of HbA1c Testing in Diabetes Diagnosis and Management
Interpretation of HbA1c in NGSP and IFCC Units as per the American Diabetes Association
Global Market Analysis and Prospects
World Hemoglobin A1C (HBA1C) Testing Market Set to Witness Rapid Growth
While Developed Regions Lead, Asia-Pacific to Spearhead Long-term Growth
Chromatography-based Hb Testing Devices Lead Market
Ion-Exchange HPLC Test for Hemoglobin A1c Makes Notable Headway as Reliable Diabetes Screening Tool
HPLC Testing for HbA1c Retains Value as Gold Standard
Ion-exchange HPLC Testing: Primary Merits for Different Stakeholders
HbA1c Testing to Witness Skyrocketing Interest with Focus on POC Testing for Diabetes
Diabetes Screening to Receive Special Thrust from Rapid Point-Of-Care HbA1c Testing
Recent Market Activity
WORLD BRANDS
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Global Competitor Market Share Positioning for 2022 & 2030
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Diabetes Prevalence and the Need for Diabetes Management to Prop-up Demand for HbA1c Monitoring Devices
World Diabetes and Population Statistics (2019, 2030 & 2045)
Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
World Diabetes Prevalence (2000-2045P)
Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
Diabetes Emerges as One of the Leading Causes of Mortality
Diabetes-Related Deaths as % of Total Deaths in Below 60 Years Population by Region: 2019
Rising Popularity of Near Patient Testing Benefits HbA1c Devices Market
Myriad Benefits of POC HbA1c Tests over Lab Tests Drives Widespread Adoption
Point-of-Care (POC) HbA1c Testing Products/Analyzers of Select Players
Laboratory-based HbA1c Testing Products/Analyzers of Select Players
Major Testing Methods in POC HbA1c Tests
High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
Increasing Obesity Levels Underpins Market Growth
Average Per Capita Annual Health Expenditure (In US$) due to Obesity
Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
Increasing Healthcare Expenditure Fuels Demand for HbA1c Testing Devices
World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021, 2023
Variants & Derivatives Affecting Accuracy of HbA1c Testing
Rising Menace of Undiagnosed Diabetes Turns Heads towards Hemoglobin A1c Testing
Number of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region for the Year 2019
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Increased Vulnerability of Diabetics to Various Health Complications Boosts Demand for Hemoglobin A1C Testing
Technology Developments Transform Diagnostics in Diabetes Care
Non-Invasive Glucose Meters and Continuous Glucose Monitors Offer Viable Alternative to Hemoglobin A1c Monitoring
Role of Hemoglobin A1C Monitoring in Patients with Chronic Kidney Disease
HbA1C Testing Holds Significance as Screening Strategy for Gestational Diabetes
Home HbA1C Testing Market
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Hemoglobin A1C (HbA1C) Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 3: World Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 4: World 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 6: World Historic Review for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 7: World 16-Year Perspective for Ion-Exchange High Performance Liquid Chromatography (HPLC) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 9: World Historic Review for Immunoassays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 10: World 16-Year Perspective for Immunoassays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Boronate Affinity Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Boronate Affinity Chromatography by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Direct Enzymatic Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Direct Enzymatic Assays by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Hemoglobin A1C (HbA1C) Testing Market Share (in %) by Company: 2022 & 2030
Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share Analysis (in %) of Leading Players in the US for 2022 & 2030
Immunoassays (Technology) Competitor Revenue Share (in %) in the US: 2022 & 2030
Boronate Affinity Chromatography (Technology) Market Share Breakdown (in %) of Major Players in the US: 2022 & 2030
Direct Enzymatic Assays (Technology) Market in the US: Percentage Breakdown of Revenues by Company for 2022 & 2030
Market Analytics
TABLE 29: USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Canada 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
TABLE 41: Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Japan 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Japan 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
TABLE 47: China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: China Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: China 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: China Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: China 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Market Facts & Figures
European Hemoglobin A1C (HbA1C) Testing Market: Competitor Market Share Scenario (in %) for 2022 & 2030
Ion-Exchange High Performance Liquid Chromatography (HPLC) (Technology) Market Share (in %) by Company in Europe: 2022 & 2030
Immunoassays (Technology) Market Share (in %) of Major Players in Europe: 2022 & 2030
Boronate Affinity Chromatography (Technology) Competitor Market Share Analysis (in %) in Europe: 2022 & 2030
Direct Enzymatic Assays (Technology) Market in Europe: Competitor Revenue Share Shift (in %) for 2022 & 2030
Market Analytics
TABLE 53: Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: Europe 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: Europe 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
TABLE 62: France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: France Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: France 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: France Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: France 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
TABLE 68: Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Germany 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Germany 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Italy 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: Italy 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
TABLE 80: UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: UK Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: UK 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: UK Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: UK 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 86: Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Spain 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 89: Spain Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Spain Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Spain 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 92: Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Russia 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 95: Russia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Russia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Russia 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Rest of Europe 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Rest of Europe 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: Asia-Pacific 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: Asia-Pacific 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: Asia-Pacific 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
TABLE 113: Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Australia 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 116: Australia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Australia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Australia 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
TABLE 119: India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: India Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: India 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 122: India Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: India Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: India 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 125: South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: South Korea 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 128: South Korea Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: South Korea Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: South Korea 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Asia-Pacific Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
TABLE 137: Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Latin America 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 140: Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Latin America 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 143: Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Latin America 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 146: Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Argentina 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 149: Argentina Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Argentina Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Argentina 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 152: Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Brazil 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 155: Brazil Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Brazil Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Brazil 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 158: Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Mexico 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 161: Mexico Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: Mexico Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: Mexico 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: Rest of Latin America 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: Rest of Latin America Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: Rest of Latin America 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
TABLE 170: Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: Middle East 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 173: Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: Middle East 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 176: Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: Middle East 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 179: Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Iran 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 182: Iran Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Iran Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Iran 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 185: Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Israel 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 188: Israel Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 189: Israel Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Israel 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Saudi Arabia 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Saudi Arabia Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Saudi Arabia 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 197: UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: UAE 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 200: UAE Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: UAE Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: UAE 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Rest of Middle East 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Rest of Middle East Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Rest of Middle East 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
TABLE 209: Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Africa 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by Technology - Percentage Breakdown of Value Revenues for Ion-Exchange High Performance Liquid Chromatography (HPLC), Immunoassays, Boronate Affinity Chromatography, Direct Enzymatic Assays and Other Technologies for the Years 2014, 2024 & 2030
TABLE 212: Africa Recent Past, Current & Future Analysis for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Africa Historic Review for Hemoglobin A1C (HbA1C) Testing by End-Use - Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Africa 16-Year Perspective for Hemoglobin A1C (HbA1C) Testing by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Diagnostic Laboratories and Other End-Uses for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings